Obesity and the clinical use of serum GGT activity as a marker of heavy drinking

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 67, Issue 5, 2007, Pages 480-488

  Puukka, K ^a,b   Hietala, J ^a,b   Koivisto, H ^a,b   Anttila, P ^a,b   Bloigu, R ^c   Niemela O ^a,b  

^a SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

Biomarkers; BMI; Ethanol; Gamma glutamyl transferase; Liver; Reference values; Sensitivity; Specificity

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ALCOHOL ABUSE; ARTICLE; BODY MASS; BODY WEIGHT; COMPARATIVE STUDY; CONTROLLED STUDY; DETOXIFICATION; DIAGNOSTIC PROCEDURE; DRINKING BEHAVIOR; ENZYME ACTIVITY; FALSE POSITIVE RESULT; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; MALE; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ADOLESCENT; ADULT; AGED; ALCOHOL DRINKING; ALCOHOLISM; BIOLOGICAL MARKERS; BODY MASS INDEX; FEMALE; FINLAND; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; OBESITY; REFERENCE VALUES; SCANDINAVIA; TEMPERANCE;

EID: 34548307087     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510601146035     Document Type: Article

References (34)

1. Zein M, Discombe G. Serum gamma-glutamyl transpeptidase as a diagnostic aid. Lancet 1970;2:748-50.
2. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001;38:263-355.
3. Niemelä O. Biomarkers in alcoholism. Clin Chim Acta 2007;377:39-49.
4. Bagrel A, d'Houtaud A, Gueguen R, Siest G. Relations between reported alcohol consumption and certain biological variables in an " unselected" population. Clin Chem 1979;25:1242-6.
5. Chick J, Kreitman N, Plant M. Mean cell volume and gamma-glutamyl- transpeptidase as markers of drinking in working men. Lancet 1981;1:1249-51.
6. Papoz L, Warnet JM, Pequignot G, Eschwege E, Claude JR, Schwartz D. Alcohol consumption in a healthy population. Relationship to gamma-glutamyl transferase activity and mean corpuscular volume. J Am Med Assoc 1981;245:1748-51.
7. Anton RF, Lieber C, Tabakoff B. Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study. Alcohol Clin Exp Res 2002;26:1215-22.
8. Conigrave KM, Davies P, Haber P, Whitfield JB. Traditional markers of excessive alcohol use. Addiction 2003;98 Suppl 2:31-43.
9. Hietala J, Puukka K, Koivisto H, Anttila P, Niemelä O. Serum gamma-glutamyl transferase in alcoholics, moderate drinkers and abstainers: effect on GT reference intervals at population level. Alcohol Alcohol 2005;40:511-14.
10. Daeppen JB, Smith TL, Schuckit MA. Influence of age and body mass index on gamma-glutamyltransferase activity: a 15-year follow-up evaluation in a community sample. Alcohol Clin Exp Res 1998;22:941-4.
11. Lawlor DA, Sattar N, Smith GD, Ebrahim S. The associations of physical activity and adiposity with alanine aminotransferase and gamma- glutamyltransferase. Am J Epidemiol 2005;161:1081-8.
12. Colicchio P, Tarantino G, Del Genio F, Sorrentino P, Saldalamacchia G, Finelli C, et al. Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in south Italy. Ann Nutr Metab 2005;49:289-95.
13. Lam GM, Mobarhan S. Central obesity and elevated liver enzymes. Nutr Rev 2004;62:394-9.
14. Peters TJ, Cook CC. Obesity as a cause of "false-positive" alcohol misuse laboratory investigations. Addict Biol 2002;7:443-6.
15. Puukka K, Hietala J, Koivisto H, Anttila P, Bloigu R, Niemelä O. Additive effects of moderate drinking and obesity on serum gamma-glutamyl transferase activity. Am J Clin Nutr 2006;83:1351-4.
16. Conway B, Rene A. Obesity as a disease: no lightweight matter. Obes Rev 2004;5:145-51.
17. Felding P, Rustad P, Mårtensson A, Kairisto V, Franzson L, Hyltoft Petersen P, et al. Reference individuals, blood collection, treatment of samples and descriptive data from the questionnaire in the Nordic Reference Interval Project 2000. Scand J Clin Lab Invest 2004;64:327-42.
18. Horn PS, Pesce AJ. Reference intervals: an update. Clin Chim Acta 2003;334:5-23.
19. Room R, Babor T, Rehm J. Alcohol and public health. Lancet 2005;365:519-30.
20. Diehl AM. Obesity and alcoholic liver disease. Alcohol 2004;34:81-7.
21. Rohrer JE, Rohland BM, Denison A, Way A. Frequency of alcohol use and obesity in community medicine patients. BMC Fam Pract 2005;6:17.
22. Seitz HK. Additive effects of moderate drinking and obesity on serum gamma-glutamyl transferase. Am J Clin Nutr 2006;83:1252-3.
23. Stranges S, Dorn JM, Muti P, Freudenheim JL, Farinaro E, Russell M, et al. Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Hepatology 2004;39:754-63.
24. Van Hoek B. Non-alcoholic fatty liver disease: a brief review. Scand J Gastroenterol 2004;241:56-9.
25. Nakanishi N, Nishina K, Li W, Sato M, Suzuki K, Tatara K. Serum gamma-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. J Intern Med 2003;254:287-95.
26. Lee DH, Ha MH, Kam S, Chun B, Lee J, Song K, et al. A strong secular trend in serum gammaglutamyltransferase from 1996 to 2003 among South Korean men. Am J Epidemiol 2006;163:57-65.
27. Stromme JH, Rustad P, Steensland H, Theodorsen L, Urdal P. Reference intervals for eight enzymes in blood of adult females and males measured in accordance with the International Federation of Clinical Chemistry reference system at 37 degrees C: part of the Nordic Reference Interval Project. Scand J Clin Lab Invest 2004;64:371-84.
28. Kornhuber J, Kornhuber HH, Backhaus B, Kornhuber A, Kaiserauer C, Wanner W. The normal values of gamma-glutamyltransferase are falsely defined up to now: on the diagnosis of hypertension, obesity and diabetes with reference to normal consumption of alcohol. Versicherungsmedizin 1989;41:78-81.
29. Lee DH, Blomhoff R, Jacobs DR, Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 2004;38:535-9.
30. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752-61.
31. Puukka K, Hietala J, Koivisto H, Anttila P, Bloigu R, Niemelä O. Age-related changes on serum GGT activity and the assessment of ethanol intake. Alcohol Alcohol 2006;41:522-7.
32. Stranges S, Trevisan M, Dorn JM, Dmochowski J, Donahue RP. Body fat distribution, liver enzymes, and risk of hypertension: evidence from the Western New York Study. Hypertension 2005;46:1186-93.
33. Klatsky AL, Morton C, Udaltsova N, Friedman GD. Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med 2006;166:1190-5.
34. Speisky H, Shackel N, Varghese G, Wade D, Israel Y. Role of hepatic gamma-glutamyltransferase in the degradation of circulating glutathione: studies in the intact guinea pig perfused liver. Hepatology 1990;11:843-9.